Flot.bio

Flot.bio

Biotechnologieforschung

Watch the best Europeans in biotech to grow. Hosted by Philip Hemme. 15k monthly views. Free.

Info

Watch the best Europeans in biotech to grow. 15k monthly views. Free. Our show is a unique addition to the European biotech podcast scene, complementing other news-focused or locally-targeted podcasts. We bring you rare long-form conversations with the best in European biotech. Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Nielsen @BII, and Edwin Moses. Your host Philip animates the conversation to dig out exciting, and sometimes contrarian ideas. Those might inspire you and help you grow. We hope you enjoy the show 😉

Website
http://flot.bio
Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Europe
Art
Privatunternehmen
Gegründet
2023
Spezialgebiete
Podcast, biotech, biotechnology, europe, Show, Media, Press und Life Sciences

Orte

Beschäftigte von Flot.bio

Updates

  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    "What makes it unique is the chemistry…It has a specific spiking pattern that stands for low toxicity." Here's a short clip from our chat with Dr. Claudia Ulbrich. Discover how Cardior Pharmaceuticals was one of the first to make microRNA (miRNA)-targeted therapeutics work for cardiac diseases. “I think in the first instance, there was a different approach to identify the right microRNA.” Learn about how the science works and the outcomes for patients. "We are reducing the target with more than 50-55%…” What do you think about this form of therapeutics?

  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    “The key elements were there for a successful IPO...” 🏆 In this new short, Marc de Garidel shares how Abivax raised the largest French IPO ever on the NASDAQ. Here’s the recipe: 🤑 Have key investors upfront 📋 Have a credible management team (previous exits, drug launches) 📈 Have strong phase II data I was impressed by the IPO, especially in a bearish market. It’s also one of the rare biotech stocks globally that is trading close to its IPO price now ($11.1 vs $11.6). What do you think? — Link to the full episode is in the comments below.

  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    In 2000, Harpreet co-founded a venture after his PhD. Now, Immatics is one of the 15 most valuable European biotechs. Great to meet him in person for the first time and to record an episode while I was in Munich 🇩🇪 We talked about the field of PRAME receptors, TCR therapeutics and Cell Therapy at large. We also spoke about the combination with mRNA therapeutics and his upbringing in a Sikh family in Germany. Full episode will be online first week of September ⏰

    • Kein Alt-Text für dieses Bild vorhanden
  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    "What is important for creating an entrepreneurial culture in the lab is open-mindedness!" In this new short, Jens Nielsen shares his secret recipe based on building one of the most entrepreneurial bio labs in Europe for 20+ years. Some key points: 🔬Most of the key findings in biotech have come out from academia, but you have to be open to find the applications. 👨👩👧👦 The best way to encourage an entrepreneurial mindset is to illustrate how to do it and get other role models in the lab. 🇺🇸 Boston is the best environment in the world for life sciences academia and innovation. It’s an inspiration for labs around the world, including his lab. I agree 💯 and think Europe needs (way) more entrepreneurial mindset in academia. What do you think? — Link to the full episode is in the comments below.

  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    New episode from Munich 🇩🇪: here’s my conversation with Dominik Schumacher of Tubulis GmbH, best founders under 40 🚀 Gain insights from a “true” biotech founder, one of the only founder-PhDs under 40 that have scaled to raise over 100M. “There’s a lot of ADC development happening [in China] and the quality is really good. It’s competition that we look at seriously and take seriously.” We talked about building a champion ADC biotech, took a deep dive into the ADC sphere, and the difference between luck and success. You can now watch and listen to the full episode for free on YouTube, Spotify or Apple (link in the comments). What do you think? 🤔

  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    Here’s a teaser to a new episode with one of the top VCs: Otello Stampacchia of Omega Funds 🙌 Learn why now is the highest competitive tension in biopharma that he has ever seen. “Lessons learned, I should have probably moved to the US earlier because it would have allowed us to scale the organisation and the fundraising faster.” We further discuss his career, especially the challenges and opportunities that came from moving to Boston over 15 years ago. You can now watch (or listen) to the full episode for free on YouTube (link in the comments), Spotify or Apple. What do you think? 🤔

  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    Good to be back in Boston 🇺🇸 to finally meet and record an episode offline with top VC Otello Stampacchia 🙌 He has a deep European background and connection. On top of having had many exits, especially in the last two years (>10!!), he's a super chilled and fun person (first guest in short on the show 😎). We talked about the highest competitive tension in biopharma now that he has ever seen. We also talked about his career, especially the challenges and opportunity he had from moving to Boston over 15 years ago. Full episode released next week ⏰ Omega Funds

    • Kein Alt-Text für dieses Bild vorhanden
  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    Here’s a teaser to a new episode with one of the top female VCs in Europe: Christina Takke from V-Bio Ventures. Be inspired by her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. “When you have different views you start a discussion with each other, you look at investment opportunities from different angles.” We also talk about her investment in Argenx when it was only three employees and the venture creation drop since 2022. You can now watch (or listen) to the full episode for free on YouTube (link in the comments), Spotify or Apple. What do you think? 🤔

  • Flot.bio hat dies direkt geteilt

    Profil von Philip Hemme anzeigen, Grafik

    Founder & CEO @ Flot.bio

    "The newer investors...deciding 'wow this is a new technology and... if they can do it in ALS they can do it in other CNS diseases." This short clip comes from our chat with Sander van Deventer of VectorY where he shares how he raised Europe's largest biotech series A of 2023. "With that shift in perception means also the potential is bigger." An inspiring story 🚀 You can find more short clips of past interviews on YouTube.

Ähnliche Seiten